Supernus Announces Third Quarter 2015 Financial Results and Raises 2015 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Supernus Pharmaceuticals (SUPN) Tops Q3 EPS by 6c
November 3, 2015 5:46 PM ESTSupernus Pharmaceuticals (NASDAQ: SUPN) reported Q3 EPS of $0.08, $0.06 better than the analyst estimate of $0.02. Revenue for the quarter came in at $38.6 million versus the consensus estimate of $38.1 million.
For earnings history and earnings-related data on Supernus Pharmaceuticals (SUPN) click here.
... More